Page last updated: 2024-11-04

succinylacetone and Disseminated Intravascular Coagulation

succinylacetone has been researched along with Disseminated Intravascular Coagulation in 1 studies

succinylacetone: inhibitor of heme biosynthesis
4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia.

Disseminated Intravascular Coagulation: A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.

Research Excerpts

ExcerptRelevanceReference
"To confirm the diagnosis of tyrosinemia, quantitative urinary succinylacetone was measured."1.31[Liver failure with coagulopathy in an infant with tyrosinemia]. ( Amir, J; Campino, G; Nussinovitch, M; Shapira, R; Voluvitz, B, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nussinovitch, M1
Campino, G1
Shapira, R1
Voluvitz, B1
Amir, J1

Other Studies

1 other study available for succinylacetone and Disseminated Intravascular Coagulation

ArticleYear
[Liver failure with coagulopathy in an infant with tyrosinemia].
    Harefuah, 2001, Volume: 140, Issue:7

    Topics: Biomarkers; Disseminated Intravascular Coagulation; Heptanoates; Humans; Infant; Liver Failure; Male

2001